NEOPLASMS, OVARIAN
Clinical trials for NEOPLASMS, OVARIAN explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS, OVARIAN trials appear
Sign up with your email to follow new studies for NEOPLASMS, OVARIAN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough ovarian cancer: targeted drug shows promise in trial
Disease control CompletedThis study tested a new drug, farletuzumab ecteribulin, which targets a protein found on many ovarian cancer cells. It was compared to standard chemotherapy in 106 women whose ovarian cancer had stopped responding to platinum-based treatments. The goal was to see if the new drug …
Matched conditions: NEOPLASMS, OVARIAN
Phase: PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New drug ESG401 shows promise in early trial for advanced cancers
Disease control CompletedThis study tested an experimental drug called ESG401 in 156 people with advanced solid tumors (including breast, lung, and colorectal cancers) who had no other treatment options. The goal was to check the drug's safety, find the right dose, and see if it could shrink tumors. The …
Matched conditions: NEOPLASMS, OVARIAN
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Escugen Biotechnology Co., Ltd • Aim: Disease control
Last updated Jun 26, 2026 15:43 UTC